1. Home
  2. BGLC vs BFRI Comparison

BGLC vs BFRI Comparison

Compare BGLC & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioNexus Gene Lab Corp

BGLC

BioNexus Gene Lab Corp

N/A

Current Price

$2.32

Market Cap

10.1M

Sector

Health Care

ML Signal

N/A

Logo Biofrontera Inc.

BFRI

Biofrontera Inc.

HOLD

Current Price

$0.80

Market Cap

9.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGLC
BFRI
Founded
2017
1997
Country
Malaysia
United States
Employees
N/A
94
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.1M
9.5M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
BGLC
BFRI
Price
$2.32
$0.80
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$2.75
AVG Volume (30 Days)
5.8K
100.2K
Earning Date
05-14-2026
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
45.78
N/A
EPS
N/A
N/A
Revenue
$9,510,646.00
N/A
Revenue This Year
N/A
$11.67
Revenue Next Year
N/A
$19.80
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.23
$0.54
52 Week High
$15.19
$1.18

Technical Indicators

Market Signals
Indicator
BGLC
BFRI
Relative Strength Index (RSI) 43.18 41.39
Support Level $2.12 $0.80
Resistance Level $2.73 $0.89
Average True Range (ATR) 0.11 0.05
MACD 0.01 -0.01
Stochastic Oscillator 34.31 24.89

Price Performance

Historical Comparison
BGLC
BFRI

About BGLC BioNexus Gene Lab Corp

BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.

About BFRI Biofrontera Inc.

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.

Share on Social Networks: